Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 387
Aptamer sequence: AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU
Target unique ID: P27958
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_381 10G-1 Protein POLG_HCV77 650 nM 50 mM Tris/HCl (pH 7.7), 30 mM NaCl, 5 mM CaCl2, 10 mM dithiothreitol and 1% BSA Elution Buffer (200 uL of 0.4 M sodium acetate, 5 mM EDTA, and 7 M urea (pH 5.5)) 9310370
Structure information of aptamer
Aptamer Sequence: AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU
The optimal secondary structure in dot-bracket notation: .....((((.......((((....)))).......))))........
The centroid secondary structure in dot-bracket notation: ................((((....))))...................
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_381 Description 10G-1
Aptamer chemistry RNA Length 47 nt
GC content 44.7% Molecular weight 15,023.91 Da
Molarity of 1 μg/μl solution 66.56 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted binding
Sequence AUUCUGUUGGCGAACUGUACGCAAGUACUGGAUGACAGCCUAUCUAU
Applications The NS3-binding region in 10G-1 can serve as a basis for designing more potential inhibitors of the NS3 protein
Target information
Type Detail Type Detail
Uniprot ID P27958 Protein name Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Gene name(s) N/A Organism Genome polyprotein [Cleaved into: Core protein precursor (Capsid protein C) (p23); Mature core protein (p21); Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); Viroporin p7; Protease NS2 (p23) (EC 3.4.22.-) (Non-structural protein 2) (NS2); Serine protease/helicase NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3 helicase) (NS3 protease) (NS3P) (Viroporin p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56/58); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)]
Status reviewed in uniprot database Length 3011
Mass 327,146 Activity regulation Inhibited by the antiviral drug hexamethylene amiloride (By similarity)
Involvement in disease N/A Catalytic activity Reaction=Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1
PDB ID(s)
1A1R;1A1V;1CWX;1HEI;1JR6;1N1L;1ONB;1R7C;1R7D;1R7E;1R7F;1R7G;1RGQ;2A4R;2F9V;2HD0;2JXF;2KDR;2N1P;2O8M;2OBO;2OBQ;2OC0;2OC1;2OC7;2OC8;2OIN;2P59;2QV1;2XI2;2XI3;2XNI;3RC4;3RC5;4CL1;4JZN;4JZO;4MWF;4N0Y;4Q0X;4XVJ;4Z0X;5EOC;5ERW;5FGB;5FGC;5JZI;5YXN;5YXU;6BQJ;6BQK;6BZU;6BZV;6BZW;6BZY;6UYD;6WO5;6WOQ;
Function Packages viral RNA to form a viral nucleocapsid, and promotes virion budding (Probable).
Activity data
Interaction ID 387
Target type Protein
Target unique ID P27958
Activity 650 nM
Binding Conditions/Buffer

50 mM Tris/HCl (pH 7.7), 30 mM NaCl, 5 mM CaCl2, 10 mM dithiothreitol and 1% BSA Elution Buffer (200 uL of 0.4 M sodium acetate, 5 mM EDTA, and 7 M urea (pH 5.5))

Assay

The binding of 10G-1 to NS3. Labeled 10G-1 was mixed with different amounts of NS3 and the RNA . protein complexes were separated on filters. The radioactivity retained on the filter was divided by the total number of counts in the reaction mixture. This ratio was plotted against the concentration of NS3 in the mixture

PubMed ID 9310370
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_270 RNA CUGUCGAACAUGCUGAGGGUAACGUACUGGCAAGCUCACCUCAGCGUAGCUAa 54.72%
Apta_93 RNA CUCCGCUAUCUAACGUAUGAUAGAAUGGAUGACUA 53.19%
Apta_520 RNA GGGAGAUCUACGGAUCUCAGGGCUCUUACGGGAGCUACAUGGAAGGAGUCCAUGUGU 52.63%
Apta_92 RNA ACAACUUAAUGCGACGUUGGUAAAGCAUAUCAAAC 51.06%
Apta_95 RNA CCGCGACAGUCGUAAGUUUUGACUGACUGAACGUU 51.06%
Apta_97 RNA UUGUCGUCUUCUCCAGUUAGUCAACGAACUUGUGU 51.06%
Apta_374 RNA GUCCCGUGCGCAAAAGUUCUUAGCGCUAGCAGUCCUAGUUGC 51.06%
Apta_521 RNA GGGUUGGGAAGAAACUGUGGCACUUCGGUGCCAGCAACCC 51.06%
Apta_575 RNA AGAGCUUGACGGUCCCGAGAGUCGAGCCCAAGCUGACACUGGACCUUUGCGGACCACGUGUUGAUCGUCG 50.00%
Apta_599 RNA GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC 50.00%
Apta_599 RNA GUCUCUGUGUGCGCCAGAGAACACUGGGGCAGAUAUGGGCCAGCACAGAAUGAGGCCC 50.00%
Apta_153 RNA CCACAGUUCAGAGGCACCGCGAACAAAACGCAAGACAGAGUGCCGACAAGAAC 49.06%
Apta_271 RNA CUGUCGAGCAUGCUCAGGGUAACGUAUAGUCAAGACACCUCAAGUGUAACU 49.02%
Apta_1143 RNA ACGAGUUGUCGCAUGUGCGGUUCAGUCUGGUCCUUCAGCACCGUACAACAA 49.02%
Apta_87 RNA UACCGACUAGCAAAACCUGCUGGCGACGUUUAGAU 48.94%
Apta_96 RNA UCGCUAAUUAUAGGCGGAGUGCGACGUUAUAAAUA 48.94%
Apta_237 RNA UUCAACGCUGUGAAGGGCUUAUACGAGCGGAUUACCC 48.94%
Apta_370 RNA GGGAGGACGCGUCGCCGUAAUGGAUGUUUUGCUCCCUG 48.94%
Apta_377 RNA CUUCGGGAUUUGAGGGUAGAAUGGGACUA 48.94%
Apta_634 RNA GGUCUUACGUCGUUCGCGACUAUUGGGAGACC 48.94%